A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Umoja Biopharma
Umoja Biopharma
St. Jude Children's Research Hospital
Massachusetts General Hospital
City of Hope Medical Center
Roswell Park Cancer Institute
OHSU Knight Cancer Institute
University of Birmingham
National Cancer Institute (NCI)
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Children's Hospital of Philadelphia
Barbara Ann Karmanos Cancer Institute
Dana-Farber Cancer Institute
Stanford University
Stanford University
Massachusetts General Hospital
Massachusetts General Hospital
Massachusetts General Hospital
City of Hope Medical Center
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center